Incidence of capsular contracture in silicone versus saline cosmetic augmentation mammoplasty: A meta-analysis.

摘要: Silicone implants for augmentation mammoplasty were first introduced in 1962 (1,2). Since then, they have undergone many changes terms of design and materials. There been at least five generations silicone to date, each using a different combination core material shell type (3). Each subsequent generation was an attempt improve their aesthetic quality feel, reduce complication rates. Cohesive gel 1993 represent the latest breast on market today (3). Despite improvements implant surgical technique, capsular contracture continues be significant problem. Reported rates clinically are between 15% 45% (2–5), with 92% these occurring year after surgery (6). A recent meta-analysis (6) found surface texturing protective against patients placed subglandular position. has no date looking effect contracture. In 1992, United States Food Drug Administration announced moratorium use implants, citing possible link rheumatic diseases cancer (1). evidence amassed discrediting claims (7–12) November 16, 2006, reapproved distribution Canada. Given that devices now more readily available surgeons, we performed determine: The (silicone versus saline) patients; and The reported who received cohesive implants. Our hypothesis, based clinical experience informal review literature, saline would contracture.